间质性膀胱炎/膀胱疼痛综合征患者生活质量及相关因素分析

doi:10.19723/j.issn.1671-167X.2021.04.005

摘要/Abstract

摘要：

目的: 评估间质性膀胱炎/膀胱疼痛综合征(interstitial cystitis/bladder pain syndrome,IC/BPS)患者的生活质量,比较其与膀胱过度活动(overactive bladder,OAB)患者之间的差异,探索影响IC/BPS患者生活质量的相关因素。方法: 收集就诊于北京医院等全国多家医学中心门诊的女性IC/BPS患者人口学资料,对患者的生活质量进行多角度问卷调查并与OAB患者资料进行对比。根据生活质量影响程度,将IC/BPS患者分为轻-中度组与重度组,分析影响IC/BPS患者生活质量的相关因素。结果: 共纳入109例IC/BPS患者,平均年龄(46.4±14.3)岁,平均病程(39.4±51.6)个月。与OAB患者相比,IC/BPS组患者的平均病程较长(P=0.008),初次因本疾病就诊的患者比例较低(P<0.001),美国泌尿协会症状指数(American Urological Association symptom index, AUA-SI)评分较高(P<0.001),体重指数(body mass index,BMI)较低(P=0.016),便秘发生率较低(P=0.006)。IC/BPS对患者家庭生活方面的影响最大,其次为出行社交。IC/BPS相关症状对患者家庭生活的影响程度评分显著高于OAB组(P=0.003),困扰IC/BPS患者的症状前三位分别是疼痛(45%)、尿频(28%)、尿急(17%),IC/BPS患者储尿期症状对生活质量影响的评分显著高于OAB患者(P<0.001),咖啡因摄入(P=0.034)、便秘(P=0.003)可能是影响IC/BPS患者生活质量的相关因素。结论: IC/BPS对患者的生活质量影响较大,咖啡因摄入、便秘可能是影响IC/BPS患者生活质量的相关因素。泌尿科医生可以建议患者通过改变饮食和生活方式以减轻症状,提高患者的生活质量。

关键词: 间质性膀胱炎, 膀胱, 过度活动性, 生活质量, 危险因素

Abstract:

Objective: To evaluate the quality of life of patients with interstitial cystitis/bladder pain syndrome (IC/BPS), to compare the difference between IC/BPS and overactive bladder (OAB) pain syndrome, and to explore the related factors affecting the quality of life of IC/BPS patients. Methods: The demographic data of female outpatients with IC/BPS in Beijing Hospital and other medical centers in China were collected. The quality of life of the patients was investigated by multi-angle questionnaires and compared with the data of OAB patients. According to the influence degree of quality of life, the patients with IC/BPS were divided into mild-moderate group and severe group. Results: In this study, 109 patients with IC/BPS were included. The average age was (46.4±14.3) years and the average course of disease was (39.4±51.6) months. Compared with the OAB patients, the patients in IC/BPS group had a longer average course of disease (P=0.008), a lower proportion of the patients of first visit for the disease (P<0.001), a higher score of the American Urological Association symptom index (AUA-SI) (P<0.001), a lower body mass index (BMI) ratio (P=0.016), and a lower incidence of constipation (P=0.006). IC/BPS had the greatest impact on family life, followed by social activity. The score of IC/BPS related symptoms on family life was significantly higher than that of the OAB group (P=0.003). The top three symptoms of the IC/BPS patients were pain (45%), frequency (28%) and urgency (17%). The score of quality of life in the IC/BPS patients was significantly higher than that in the OAB patients (P<0.001). Caffeine intake (P=0.034) and constipation (P=0.003) might be the factors influencing the quality of life of the patients with IC/BPS. Conclusion: IC/BPS has a great influence on the quality of life of patients. Caffeine intake and constipation may be related factors affecting the quality of life of patients with IC/BPS. Urologists should recommend changes in diet and lifestyle to reduce symptoms and improve the patients’ quality of life.

Key words: Interstitial cystitis, Urinary bladder, overactive, Quality of life, Risk factors

中图分类号:

R694

王佳文,刘敬超,孟令峰,张威,刘晓东,张耀光. 间质性膀胱炎/膀胱疼痛综合征患者生活质量及相关因素分析[J]. 北京大学学报（医学版）, 2021, 53(4): 653-658.

WANG Jia-wen,LIU Jing-chao,MENG Ling-feng,ZHANG Wei,LIU Xiao-dong,ZHANG Yao-guang. Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome[J]. Journal of Peking University (Health Sciences), 2021, 53(4): 653-658.

图/表 4

表1

表2

表3

表4

参考文献 23

[1]	Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: Epidemiology, pathophysiology and evidence-based treatment options [J]. Eur J Obstet Gynecol Reprod Biol, 2014, 175:30-37 doi: 10.1016/j.ejogrb.2013.12.041 pmid: 24480114
[2]	Berry SH, Elliott MN, Suttorp M, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States [J]. J Urol, 2011, 186(2):540-544. doi: 10.1016/j.juro.2011.03.132
[3]	Tripp DA, Nickel JC, Krsmanovic A, et al. Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome [J]. Can Urol Assoc J, 2016, 10(11/12):383-388.
[4]	Hanno PM, Erickson D, Moldwin R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment [J]. J Urol, 2015, 193(5):1545-1553. doi: 10.1016/j.juro.2015.01.086
[5]	Gormley EA, Lightner DJ, Faraday M, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment [J]. J Urol, 2015, 193(5):1572-1580. doi: 10.1016/j.juro.2015.01.087 pmid: 25623739
[6]	Hung MJ, Chou CL, Yen TW, et al. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study [J]. J Formos Med Assoc, 2013, 112(5):276-282. doi: 10.1016/j.jfma.2011.09.020
[7]	Jhang JF, Kuo HC. Pathomechanism of interstitial cystitis/bladder pain syndrome and mapping the heterogeneity of disease [J]. Int Neurourol J, 2016, 20(Suppl 2):S95-S104. doi: 10.5213/inj.1632712.356
[8]	Birder LA. Pathophysiology of interstitial cystitis [J]. Int J Urol, 2019, 26(Suppl 1):12-15. doi: 10.1111/iju.2019.26.issue-S1
[9]	那彦群, 叶章群, 孙颖浩, 等. 膀胱过度活动症诊断与治疗指南 [M]. 北京: 人民卫生出版社, 2014: 330-335.
[10]	Hagovska M, Švihra J, Buková A, et al. The relationship between overweight and overactive bladder symptoms [J]. Obes Facts, 2020, 13(3):297-306. doi: 10.1159/000506486
[11]	Raju R, Linder BJ. Evaluation and treatment of overactive bladder in women [J]. Mayo Clin Proc, 2020, 95(2):370-377. doi: 10.1016/j.mayocp.2019.11.024
[12]	Beckett MK, Elliot MN, Clemens JQ, et al. Consequences of interstitial cystitis/bladder pain symptoms on women’s work participation and income: Results from National Household Sample [J]. J Urol, 2014, 191(1):83-88. doi: 10.1016/j.juro.2013.07.018 pmid: 23872030
[13]	Vasudevan V, Moldwin R. Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome [J]. Asian J Urol, 2017, 4(1):50-54. doi: 10.1016/j.ajur.2016.08.014 pmid: 29264207
[14]	McKernan LC, Walsh CG, Reynolds WS, et al. Psychosocial co-morbidities in interstitial cystitis/bladder pain syndrome (IC/BPS): A systematic review [J]. Neurourol Urodyn, 2018, 37(3):926-941. doi: 10.1002/nau.v37.3
[15]	Watkins KE, Eberhart N, Hilton L, et al. Depressive disorders and panic attacks in women with bladder pain syndrome/interstitial cystitis: A population-based sample [J]. Gen Hosp Psychiatry, 2011, 33(2):143-149. doi: 10.1016/j.genhosppsych.2011.01.004
[16]	Naliboff BD, Stephens AJ, Afari N, et al. Widespread psychosocial difficulties in men and women with urologic chronic pelvic pain syndromes: Case-control findings from the multidisciplinary approach to the study of chronic pelvic pain research network [J]. Urology, 2015, 85(6):1319-1327. doi: 10.1016/j.urology.2015.02.047 pmid: 26099876
[17]	Yu WR, Peng TC, Yeh HL, et al. Anxiety severity does not influence treatment outcomes in patients with interstitial cystitis/bladder pain syndrome [J]. Neurourol Urodyn, 2019, 38(6):1602-1610. doi: 10.1002/nau.v38.6
[18]	Thong ISK, Jensen MP, Miró J, et al. The validity of pain intensity measures: What do the NRS, VAS, VRS, and FPS-R mea-sure? [J]. Scand J Pain, 2018, 18(1):99-107. doi: 10.1515/sjpain-2018-0012 pmid: 29794282
[19]	Ölçücü MT, Aydın ME, Avcı S, et al. Comparison of a visual prostate symptom score and international prostate symptom score: A prospective multicenter study and literature review [J]. Urology, 2020, 146:230-235. doi: 10.1016/j.urology.2020.09.001
[20]	张维宇, 王焕瑞, 刘献辉, 等. 尿流率视觉量表的开发 [J]. 北京大学学报(医学版), 2020, 52(4):684-687.
[21]	Thu JHL, Vetter J, Lai HH. The severity and distribution of nonurologic pain and urogenital pain in overactive bladder are intermediate between interstitial cystitis and controls [J]. Urology, 2019, 130:59-64. doi: 10.1016/j.urology.2019.03.030
[22]	Shorter B, Lesser M, Moldwin R, et al. Effect of comestibles on symptoms of interstitial cystitis [J]. J Urol, 2007, 178(1):145-152. doi: 10.1016/j.juro.2007.03.020
[23]	Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions [J]. BJU Int, 2012, 109(11):1584-1591. doi: 10.1111/j.1464-410X.2011.10860.x pmid: 22233286

相关文章 15

[1]	魏慧, 张警丰, 姚中强, 赵金霞. 类风湿关节炎合并慢性病贫血患者的临床特征及相关因素[J]. 北京大学学报（医学版）, 2026, 58(2): 307-312.
[2]	郭睿霖, 张蕾, 王宇, 王晓庆, 王潇潇, 年凇汶, 张丽慧, 肖冰冰, 陆叶. 经闭孔尿道中段无张力悬吊改良术治疗女性压力性尿失禁的疗效[J]. 北京大学学报（医学版）, 2026, 58(2): 337-341.
[3]	赵杰, 付春, 赵秀娟, 薛海岩, 李纾, 王振洲, 朱凤雪. 胸部创伤患者在重症监护病房内发生呼吸机相关性肺炎的危险因素[J]. 北京大学学报（医学版）, 2026, 58(2): 351-358.
[4]	郭芷均, 俎明, 马超, 张贺军, 张静, 丁士刚. 同时性多发早期胃癌漏诊病灶的临床病理特征[J]. 北京大学学报（医学版）, 2026, 58(2): 410-415.
[5]	李岩岩, 刘香君, 李公明, 李春, 贾园. 抗磷脂综合征患者就医行为及治疗现状调查[J]. 北京大学学报（医学版）, 2025, 57(6): 1107-1112.
[6]	李博闻, 张强, 孙益鑫. 儿童及青年漏斗胸患者Nuss术后发生脊柱侧弯的风险预测模型建立及验证[J]. 北京大学学报（医学版）, 2025, 57(5): 941-946.
[7]	杨小勇, 张帆, 马潞林, 刘承. 前列腺导管腺癌临床特征及腺外侵犯的影响因素[J]. 北京大学学报（医学版）, 2025, 57(5): 956-960.
[8]	李慎谟, 苏丹丹, 林己煜, 宋昊东, 马潞林, 侯小飞, 王国良, 张洪宪, 叶剑飞, 张树栋. 腹腔镜下膀胱癌根治术同期行肾输尿管全长切除术的预后分析[J]. 北京大学学报（医学版）, 2025, 57(5): 961-966.
[9]	缪祺, 洪保安, 张学舟, 孙志鹏, 王维, 王宇轩, 薄予轩, 赵佳晖, 张宁. 膀胱癌合并冠心病患者行经尿道膀胱肿瘤切除术围手术期抗血小板药物管理[J]. 北京大学学报（医学版）, 2025, 57(4): 698-703.
[10]	刘伟, 郭稳, 过哲, 李春艳, 李云龙, 刘思奇, 张亮, 宋慧. 痛风患者放射学阴性骨侵蚀的相关危险因素[J]. 北京大学学报（医学版）, 2025, 57(4): 735-739.
[11]	黄万伟, 沙显燊, 张艺宝, 伍国豪, 骆峰, 陈智慧, 叶东明, 李学松, 赖彩永. 完全3D腹腔镜回肠代双侧输尿管联合膀胱扩大术修复放射治疗后双侧输尿管狭窄并膀胱挛缩[J]. 北京大学学报（医学版）, 2025, 57(4): 789-795.
[12]	陆梦溪, 刘秋萍, 周恬静, 刘晓非, 孙烨祥, 沈鹏, 林鸿波, 唐迅, 高培. 基于社区人群队列的甘油三酯-葡萄糖指数与心血管病发病和死亡的关联[J]. 北京大学学报（医学版）, 2025, 57(3): 430-435.
[13]	杨龙傲, 金旭, 黄文初, 何丽华, 陈娟. 视屏作业人员视疲劳及干眼的流行病学调查[J]. 北京大学学报（医学版）, 2025, 57(3): 554-561.
[14]	刘宁, 满立波, 何峰, 黄广林, 翟建坡. 良性前列腺增生患者排尿中断症状与尿动力学指标的相关性[J]. 北京大学学报（医学版）, 2025, 57(2): 328-333.
[15]	郭华秋, 王哲, 杨雪, 白洁. 口腔急诊出血患者的临床特征与危险因素[J]. 北京大学学报（医学版）, 2025, 57(1): 142-147.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

Items	IC/BPS (n=109)	OAB (n=461)	P value
Age/years, $\bar{x}±s$	46.4±14.3	46.2±13.1	0.852
Disease duration/months, $\bar{x}±s$	39.4±51.6	27.0±40.8	0.008
BMI, $\bar{x}±s$	22.1±2.8	22.9±3.0	0.016
Smoking, n (%)			0.315
No	108 (99.1)	446 (96.7)
Yes	1 (0.9)	15 (3.3)
Drinking, n (%)			0.759
No	106 (97.2)	453 (98.3)
Yes	3 (2.8)	8 (1.7)
Caffeine intake, n (%)			0.956
No	103 (94.5)	435 (94.4)
Yes	6 (5.5)	26 (5.6)
Constipation, n (%)			0.006
No	91 (83.5)	325 (70.5)
Yes	18 (16.5)	136 (29.5)
Marital status, n (%)			0.090
Married	98 (89.9)	435 (94.4)
Unmarried or divorced	11 (10.1)	26 (5.6)
First visit due to LUTS, n (%)			<0.001
No	29 (26.6)	21 (4.6)
Yes	80 (73.4)	440 (95.4)
OABSS scores, $\bar{x}±s$	7.1±3.2	6.6±3.2	0.210
AUA-SI scores, $\bar{x}±s$	14.5±6.7	11.7±5.9	<0.001

Items	IC/BPS (n=109), M (P₂₅, P₇₅)	OAB (n=461), M (P₂₅, P₇₅)	P value
Social activities	4 (3, 5)	4 (3, 5)	0.165
Work	2 (1, 3)	2 (1, 4)	0.116
Sports	2 (0, 3)	2 (1, 4)	0.057
Daily life	4 (4, 5)	4 (3, 5)	0.003
Sexual life	2 (0, 4)	2 (1, 4)	0.251
Psychological emotions	2 (0, 3)	2 (1, 4)	0.187

Impacts on quality of life score	IC/BPS (n=109), M (P₂₅, P₇₅)	OAB (n=461), M (P₂₅, P₇₅)	P value
Storage symptoms	8 (6, 8)	6 (5, 7)	<0.001
Voiding symptoms	3 (1, 6)	4 (1, 5)	0.846
Post-voiding symptoms	4 (1, 6)	4 (1, 6)	0.735

Items	Mild and moderate (n=46)	Severe (n=63)	P value
Age/years, $\bar{x}±s$	48.4±15.6	45.0±13.3	0.302
Disease duration/months, $\bar{x}±s$	40.9±56.4	38.3±48.3	0.789
BMI, $\bar{x}±s$	21.8±2.7	22.3±2.9	0.805
Smoking, n (%)			0.578
No	46 (100.0)	62 (98.4)
Yes	0 (0)	1 (1.6)
Drinking, n (%)			0.189
No	46(100.0)	60 (95.2)
Yes	0 (0)	3 (4.8)
Caffeine intake, n (%)			0.034
No	46 (100.0)	57 (90.5)
Yes	0 (0)	6 (9.5)
Constipation, n (%)			0.003
No	44 (95.7)	47 (74.6)
Yes	2 (4.3)	16 (25.4)
Marital status, n (%)			0.234
Married	43 (93.5)	55 (87.3)
Unmarried or divorced	3 (6.5)	8 (12.7)
First visit due to LUTS, n (%)			0.548
No	12 (26.0)	17 (27.0)
Yes	34 (74.0)	46 (73.0)